Camille Kotton, MD, FIDSA, FAST

Course Director
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Mass General Brigham Endowed Cancer Chair IV
Massachusetts General Hospital
Associate Professor, Harvard Medical School
Boston, Massachusetts

Financial relationships

Attribution:
Self

Type of financial relationship:
Consultant

Ineligible company:
Takeda QIAGEN Takeda Evrys Biotest Kamada Abbott Labs Roche Diagnostics

Topic:
CMV

Date added:
10/11/2026

Date updated:
10/11/2026

Return to Navigating Modern CMV Antivirals: Applying Guideline Updates to Clinical Practice